Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.48 |
| ▸ | FGFR2 | P21802 | 2/20 | 0.48 |
| ▸ | F10 | P00742 | 8/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30863442 | 0.81 | NPC1 (0.54) | F10 | |
| SCHEMBL30863450 | 0.79 | TRPV1 (0.57) | WDR5FGFR1FGFR2MAPT | |
| SCHEMBL27195688 | 0.79 | TRPV1 (0.57) | WDR5FGFR1FGFR2MAPT | |
| SCHEMBL27195704 | 0.77 | HTR1D (0.42) | WDR5MEN1KMT2AABCB1MAPT | |
| SCHEMBL30863420 | 0.77 | HTR1D (0.42) | WDR5MEN1KMT2AABCB1MAPT | |
| Hydrochloric Acid SCHEMBL30863555 | 0.76 | F10 (0.56) | F10 | |
| SCHEMBL30863427 | 0.75 | HDAC3 (0.52) | FGFR1 | |
| SCHEMBL30863502 | 0.74 | HDAC3 (0.59) | WDR5F10 | |
| SCHEMBL9979804 | 0.73 | F10 (0.76) | F10 | |
| SCHEMBL30863419 | 0.73 | WDR5 (0.44) | WDR5MEN1KMT2AABCB1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | claimed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | claimed |
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | disclosed |